A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis
Clinical trial NCT02963506 · COMPLETED
Trial details
- NCT number
- NCT02963506
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-10-01
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.